OUTSOURCING
We Are Altasciences: Proactive Drug Development
When you partner with Altasciences, you get a single source outsourcing partner who knows your program from end to end and who can anticipate your needs, for a seamless and simplified experience.
Mitigating Risk And Complexity In Cell & Gene Therapy Trials With IRT
CGT pioneers require supply chain partnerships that mitigate trial risk and complexity. Explore how to optimize pre-trial and pre-screening activities and reduce trial cost and risk with an IRT solution.
Streamlining Patient Access To Cell And Gene Therapies
Learn about the obstacles patients encounter when seeking CGTs and explore how technology and patient services can empower manufacturers and clinical teams to help patients overcome barriers.
Meetings That Move Studies Forward
Explore how fully managed virtual meeting services support clinical research teams with registration, secure portal access, live facilitation, and post-meeting deliverables handled from start to finish.
Multi-Site Capabilities For Your Phase I-II Trials
Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired patient populations.
An Innovative Approach To Functional Outsourcing
The shifting dynamics of clinical research from the current funding dynamic to the increased complexity of drug development, requires a different approach to functional outsourcing to be successful.
The Unique Attributes of Psychedelic Drug Development
Navigate key considerations for psychedelic clinical development, from FDA recommendations and abuse potential evaluation to blinding and early-phase trial design.
We Mapped What Sites Actually Do To Prepare Source Docs - The Results Are Eye-Opening
New global research shows how sites prepare source documents, where inefficiencies occur, and why workflows differ — highlighting ways to streamline processes, cut delays, and improve data quality.
Altasciences Clinical Services At A Glance
We can support your entire drug development program end to end, or you can partner with us for just one element. We offer you complete flexibility.
See How You Can Start Your Early Phase Program 6-9 Weeks Earlier In Canada
Vice President of Business Development Lisa Sanford explains whether you need an IND before starting your first-in-human trial in Canada.
How Sponsors Turn Disclosure As A Service Into A Strategic Advantage
In this panel discussion, Teva and Lung Biotechnology disclosure experts discuss why they opted for disclosure as a service. They will detail how it helps them safeguard regulatory compliance and mitigate risk.
Ensuring Reliable Clinical Trial Material Production
As an integrated CRO/CDMO, Altasciences combines formulation and pharmacy expertise to optimize drug products, support clinical trials, and help resolve challenges that could impact development timelines.
Imagine… Easier, Proactive Drug Development
Imagine partnering with a single CRO/CDMO for your early phase drug development. With Altasciences, you don’t have to imagine—learn how they’re able to deliver for your project.
How To Take Advantage Of Early Access Programs For The EU
Learn how to leverage Early Access Programs (EAPs) in the EU to expedite market entry for innovative life science products. Gain insights into running successful EAPs, including crucial steps for France.
Central eSource: Leveraging Site Technology
In this presentation, CRIO founder and co-CEO Raymond Nomizu delves into how sponsors can leverage the electronic source trend among sites through the use of Central eSource.
Improve Trial Readiness With Tech-Enabled FSP Delivery Models
Struggling with slow study starts or operational strain? See how technology-enabled FSP models help trials launch faster and run more smoothly.
Getting Buy-In For Disclosure As A Service
Clinical trial disclosure teams often have a tough time convincing upper management on the benefits of Disclosure as a Service. Hear how two sponsors “sold” the idea of outsourcing this function. Watch the short TrialScope interview.
The Heart Of The Matter: Early Vs. Late QT Prolongation Testing
Dr. Beatrice Setnik, Altasciences' Chief Scientific Officer, walks through the differences between early and late QT prolongation testing.
Improving Sponsor Oversight Of The Trial Master File
In the face of increasing documentation requirements and trial complexity, discover how global biopharmaceutical company Chiesi and its CRO partners collaborated to ensure ongoing oversight compliance.
The Path Forward, Altasciences' Approach To Project Management
Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.
Early Phase Clinical Development Solutions
Our experts in the design and conduct of clinical pharmacology and early efficacy studies ensure that data generated meets your objectives.
Successful Implementation Of A Drug-Device Combination Submission
Projects including both drug and device components require strategic planning for smooth initiation. Regulatory considerations are the key to success.
Altasciences Has You Covered From Coast To Coast
With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.
Proactive Drug Development: Explained
Watch this short video to learn about Proactive Drug Development with Altasciences.
The Power Of Partnership: Connecting 1M+ Patients To Clinical Research
Embedding studies within a health system's community hospitals gives sponsors a route to patients already in care, with implications for referral pathways and enrollment speed.
How To Boost Disclosure Efficiencies With Outsourcing
In this webinar, you’ll hear about exciting new advisory and managed disclosure services from TrialScope, including: compliance, policy and process assessments, as well as plain-language summaries, protocol registration, results posting, and redaction services.
...
A Different Kind Of CRO
Altasciences is an award-winning, forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development.
Switching IRT/RTSM Providers Shouldn't Feel Like Moving Mountains | Korio Makes It Easy
Unveil how structured, repeatable processes can turn RTSM migrations from high‑risk undertakings into predictable transitions.
Big Impact With A Personal Touch
Transforming lives. Improving human health. Bringing new therapies to life. Altasciences' CRO and CDMO services deliver.
Trends In Sponsor-Of-Choice Initiatives: Consolidating Site Payments
Listen in as leaders from Bristol Myers Squibb, CenExel Centers of Excellence, and IQVIA Technologies discuss the importance of providing a consistent clinical trial payment experience to sites.